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ABSTRACT  
Objectives: To establish the diagnostic accuracy of obstetric ultrasound at a tertiary 
fetal medicine centre in the prenatal detection of unilateral and bilateral MCDK in 
fetuses where this condition was suspected; and to undertake a systematic review of 
the literature on this topic.  
Methods: Retrospective observational study of all cases with an antenatal diagnosis 
of either unilateral or bilateral MCDK referred to a regional tertiary fetal medicine 
unit between 1997 and 2015.  Postnatal diagnosis was confirmed by postnatal 
ultrasound reports or postmortem examination. The accuracy for prenatal ultrasound 
in the diagnosis of MCDK was calculated. We also performed a review of the 
literature using a systematic search strategy, regarding the prenatal diagnosis and 
diagnostic accuracy of MCDK. 
 
Results: We included 144 women in the analysis; 37 (25.7%) opted for pregnancy 
termination (due to unilateral MCDK with additional abnormalities, bilateral 
suspected MCDK or severe obstructive uropathy). In 126 women all pre- and 
postnatal data were available, including 104 livebirths; 19 who opted for TOP and 
where PM was available; and 3 that had an intrauterine fetal death. Two infants died 
shortly after birth, (due to known bilateral MCDK and known cranial vault defect). 
The overall number of postnatally confirmed MCDK was 100: of these 98 were 
diagnosed prenatally (true positive), while 2 were thought to be hydronephrosis 
prenatally (false negative) and the diagnosis of MCDK was made after birth. In 9 
cases the initial antenatal diagnosis of suspected MCDK was revised, either later in 
pregnancy (n=2) or postnatally (n=7). The overall diagnostic accuracy of MCDK 
reported in the existing literature was found to range from 53.3 to 100%. MCDK was 
isolated in the majority of cases, while in 29% of cases was found to be associated 
with other renal and extra-renal fetal abnormalities. 
Conclusions:  Our study suggests that the diagnostic accuracy for the use of antenatal 
ultrasound to detect postnatal MCDK was about 91% and can therefore be used to 
guide antenatal counselling. However, prenatal or postnatal revision of the diagnosis 
occurs in about 7% of cases and parents should be counselled appropriately. 
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INTRODUCTION 
 
Multicystic dysplastic kidney disease (MCDK) is defined as a non-heritable form of 
renal dysplasia that usually leads in a non-functioning organ due to an abnormal 
kidney development1. Several decades ago Potter et al. suggested that MCDK could 
be due to a primary failure of renal mesenchyme induction, resolving in the complete 
absence of nephrons2; however, this theory has been challenged because kidneys 
affected do sometimes contain some recognizable glomeruli and proximal tubules3. 
An alternative view is that disruption of normal nephrogenesis could, at least in part, 
be explained by impairment of fetal urine flow very early in fetal life, and MCDK is 
generally attached to an ‘atretic’, non-patent ureter4,5.  
 
Antenatally, MCDK is one of the commonest renal anomalies detected on prenatal 
ultrasound with an incidence between 1 in 1000 to 1 in 4300 live births6,7. The 
classical sonographic appearance is the presence of multiple, hypoechoic, non-
communicating cysts with no identifiable normal renal parenchyma7,8. Exploration of 
the renal fossa in some cases reveals no renal artery, renal vein, ureter or cysts, 
suggesting that renal agenesis and dysplastic kidneys may be at different 
ends of a spectrum of renal malformation. This is further supported by the finding 
that, in about 15% of cases with multicystic kidneys, there is contralateral renal 
agenesis. The condition is usually detected at the mid-trimester scan and although 
demonstration as early as 15 weeks of gestation has been reported9, such early 
detection is unusual: overall detection rates of genitourinary abnormalities during the 
first trimester of pregnancy are about 34%; the reported detection rates specifically for 
MCDK are only about 14 %10,11. 
 
Unilateral MCDK with no associated fetal abnormalities and a normal contralateral 
kidney is associated with an excellent prognosis; in contrast, bilateral MCDK means 
that fetal and neonatal renal function is absent, with associated anhydramnios and 
pulmonary hypoplasia, a condition generally considered incompatible with extra-
uterine life12-14; this demonstrates the importance of accurate characterisation of 
MCDK. Although the appearance of MCDK is characteristic, it may be confused with 
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other renal anomalies, in particular hydronephrosis with calyceal involvement6,15. The 
purpose of this study was to establish the diagnostic accuracy of prenatal ultrasound 
after initial referral for suspected MCDK using a cohort design in our centre; and by 
undertaking a review of the literature regarding the prenatal diagnosis and diagnostic 
accuracy of MCDK.  
 
METHODS 
Assessment of our cases 
This is a retrospective study of all cases with an antenatal diagnosis of either 
unilateral or bilateral MCDK referred to our tertiary fetal medicine unit at St George’s 
hospital, London. All cases were identified from the computerized ultrasound 
database (Viewpoint, Viewpoint Corporation, GE Healthcare, Austria) over an 18-
year period from May 1997 to September 2015.  This database includes women 
identified during routine screening in our local population; as well as referrals from 
all units within the south west London population. All women identified had the 
antenatal diagnosis of MCKD confirmed by a senior fetal medicine consultant; the 
doctors scanning the women were not blinded to the suspected antenatal diagnosis.  
The postnatal diagnosis was confirmed by findings documented on postnatal 
ultrasound or postmortem reports. This information was gathered by reviewing 
information in case notes, radiology databases and electronically recorded clinic 
letters, either in our hospital or in the referring unit.  In some children no cystic renal 
tissue was seen on postnatal scan, rather absence of renal tissue. Given the natural 
history of MCDK, this was interpreted as confirmation of the antenatal diagnosis 
rather than misdiagnosed renal agenesis. All other postnatal diagnoses were 
considered as the “gold standard”. Clinicians performing postnatal imaging; and those 
collecting outcome data were not blinded to the antenatal diagnosis of MCKD.   
Cases were defined as false negative where a diagnosis of MCDK was established 
postnatally and where antenatal reports had suspected a renal abnormality; the only 
exception was when unilateral MCDK was suspected in the contralateral kidney (i.e. 
there was a right-left error).  Finally, in women who opted for a termination of 
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pregnancy (TOP) but declined post-mortem, it was not possible to establish a 
postnatal diagnosis. 
From these data, the accuracy for the antenatal ultrasound diagnosis of MCDK by 
ultrasound was calculated. 
Systematic review 
A systematic search strategy was developed and undertaken in PubMed, EMBASE 
and Scopus to identify citations reporting the diagnostic accuracy of antenatal 
ultrasound for MCDK. We used medical subject heading (MeSH) terms and key 
words, and word variants for “Multicistyc dysplastic kindey deasease” and “prenatal 
diagnosis”. The search and selection criteria were restricted to the English language. 
Reference lists of relevant articles and reviews were hand searched for additional 
reports. The inclusion criteria were studies reporting data on the prenatal diagnosis 
and diagnostic accuracy of MCDK. Two authors (CS, ULRM) reviewed all the 
abstracts independently. Agreement about potential relevance was reached by 
consensus, and full text copies of those papers were obtained. Two reviewers (CS, 
ULRM) independently extracted relevant data regarding study characteristics and 
pregnancy outcome. Inconsistencies were discussed by the reviewers and if needed a 
third author (ATP) and consensus reached. Only full text articles were considered 
eligible for the inclusion. Case reports, and conference abstracts were also excluded. 
 
 
 
 
RESULTS 
During the study period 189 patients were seen in the unit for suspected unilateral or 
bilateral MCDK (Figure 1). In 45 cases no further pregnancy nor postnatal follow up 
was undertaken and these were excluded from the subsequent analysis; in all but one 
of these the diagnosis was unilateral suspected MCDK, while in 1 case there was an 
associated cardiac abnormality but the woman moved abroad. There were no major 
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differences in maternal and ultrasound characteristics of patients with and without 
follow-up (Table 1).  
 
Diagnosis 
In 144 cases data were available and these were included in the analysis (Figure 1). 
The median gestational age (GA) at the time of the initial scan was 22.0 weeks (IQR 
21.4-23.7). The median number of follow up scans was 2 (2-3). In 101 (69.4%) there 
was unilateral suspected MCDK while in 25 (17.4%) there was bilateral suspected 
MCDK. Associated abnormalities were present in 28 of the 144 cases (21 in the 
unilateral group and 7 in the bilateral group, Table 2). 
Outcomes 
Of the 144 women, 37 (25.7%) opted for TOP: in 11 women this was due to unilateral 
suspected MCDK with additional abnormalities conferring a poor prognosis; in 23 
there was bilateral suspected MCDK (of these 7 were non-isolated: 4 cases of Meckel 
Gruber syndrome were found, in 1 case there was VACTERL and in one case mosaic 
trisomy 13 was found, Table 2), while in the remaining 3 cases the initial diagnosis 
was a severe obstructive uropathy.  
Of the 144 cases, a TOP was performed and no postmortem examination was 
available in 18; in the remaining 126 cases all pre- and postnatal data were available. 
This included 104 livebirths; 19 women who opted for TOP and where PM was 
available (included in the 37, above); and 3 women (2.4%) where an intrauterine fetal 
death occurred: one for unknown reasons at 36 weeks in a diabetic mother, with a 
birthweight of 3.5kg; one in a fetus with IUGR at 32 weeks; and one in a fetus with 
preterm prelabour rupture of the membrane and obstructive uropathy at 31 weeks of 
gestation. Of the 104 liveborn infants two (1.8%) died shortly after birth: both were 
expected, where the parents elected to continue with the pregnancy: one with lethal 
pulmonary hypoplasia secondary to bilateral MCDK and anhydramnios, and one with 
a cranial vault defect.  
The diagnostic accuracy for MCDK 
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Of the 126 cases, the overall number of postnatally confirmed MCDK was 100: of 
these 98 were diagnosed prenatally (true positive), while 2 were thought to be 
hydronephrosis prenatally (false negative) and the diagnosis of MCDK was made 
after birth.  
In 9 cases the initial antenatal diagnosis of suspected MCDK was revised (false 
positive): In 2 of these this was revised later in pregnancy to moderate hydronephrosis 
during the third trimester of pregnancy and confirmed postnatally; while in the 
remaining 7 cases the diagnosis was revised postnatally (Table 3, Figure 1 and Figure 
2). 
The screening characteristics for ultrasound in relation to the diagnosis of MCDK are 
shown in Table 4. Overall, the diagnostic accuracy for the use of antenatal ultrasound 
to detect postnatal MCDK was 91.2%.  
Systematic review 
The literature review yielded 252 possible citations. After reviewing title or abstract, 
207 were excluded, as they did not meet the selection criteria. The remaining 45 full-
text manuscripts were retrieved and a total of 7 eligible studies were included in the 
systematic review, (Figure 3, Flow chart). 
The characteristics of the included studies are presented in Table 5.  The overall 
diagnostic accuracy of MCDK reported ranged widely between 53.3 and 100%. 
Prenatal diagnosis was made mainly during the third trimester of pregnancy (mean 
GA was 26 weeks). The condition was isolated in the majority of cases, while in 29% 
of the cases was found to be associated with other renal or extra-renal anomalies. In 
total, 653 (77.6%) fetuses were liveborn, 19 (2.3%) suffered an IUD, and 3 (0.4%) 
fetuses died shortly after birth because of associated abnormalities; while 166 (19.7%) 
underwent a TOP (Table 5).    
 
 
DISCUSSION 
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The data from this study showed that the antenatal prediction of unilateral or bilateral 
MCDK appears accurate in about 91.2% of cases. However, in an important number 
of cases (7.2%) the diagnosis was revised, either later in pregnancy; or postnatally. 
Although the prognosis was thus largely unaltered, parents should be made aware of 
this information at the time of the diagnosis at the mid-trimester anomaly scan. 
Moreover, it needs to be highlighted that in some cases the revised diagnosis of 
hydronephrosis might be the consequence of the prolonged urinary obstruction in an 
originally multicystic kidney, making a possible evolution of the disease a revised 
diagnosis16.  In addition, our data suggest that, despite the high accuracy of antenatal 
prediction of MCDK, both follow up antenatal scans and postnatal imaging still 
needed in infants diagnosed antenatally17,18. 
Chromosomal abnormalities and syndromes were found in approximately 7% of 
pregnancies referred with suspected MCDK, and this is in line with the prevalence 
reported in the current literature19,20. The presence of other associated malformations 
was found in almost 1 in 5 cases with MCDK. This is similar to the study by Eckoldt 
et al.21, who reported 23.4% of fetuses with MCKD had associated extra-renal 
malformations of other organ systems. The frequency of women who underwent a 
TOP for lethal abnormalities in addition to those that end in an IUD/NND because of 
renal complications was 25%, similar to the prevalence in previous reports 30%22 
(Table 5).  This association with anomalies highlights the need for detailed antenatal 
assessment for co-existing renal or extra-renal anomalies. This, more than any other 
factor, will alter antenatal counselling – at one end of the spectrum an isolated 
unilateral MCKD with a normal contralateral kidney conferring an excellent 
prognosis and at the other, lethal multi-organ syndromes or chromosomal 
abnormalities that are incompatible with life. Hence, referral to a tertiary centre 
should always be considered unless a high level of local expertise is available. 
A previous study of 85 cases of antenatally diagnosed MCDK suggested that prenatal 
ultrasound is associated with a sensitivity of 53%. Our data suggest a diagnostic 
accuracy of 92.3%, and one possible explanation for this difference could be the 
improvement during the last 10 years of the level of the operator skills in fetal 
medicine and better ultrasound technology available nowadays.  Nevertheless, we 
cannot exclude the possibility of missed diagnoses or referral bias as contributing to 
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this difference, thought this is unlikely due to the structured referral pathways in the 
entire region for both fetal medicine and nephrology services.  
The strengths of our study are the large number of included cases, detailed antenatal 
assessment in a specialist fetal medicine centre and postnatal assessment using a 
unified protocol. However, our study has certain limitations. Firstly, we assumed that 
postnatal imaging is the gold standard by which renal tract anomalies can be 
diagnosed. Given the larger object of interest and clearer views postnatally we think 
this is a reasonable assumption23. Secondly, we had a loss-to-follow up rate of 23.8% 
and this may have biased the data we are able to report. Nevertheless, maternal and 
scan characteristics for the cases lost to follow-up were similar to those with follow 
up, suggesting a random (rather than systematic) loss; thus we have no reason to 
suspect that these data would vary greatly. Finally, because we are a tertiary referral 
centre that serves a large number of hospitals in London, we have no information on 
cases where MCDK was diagnosed postnatally but had not been suspected 
antenatally. While this prevents us from being able to properly calculate the number 
of false negative cases and specificity, we can still calculate diagnostic accuracy data 
on those with an antenatal diagnosis. We believe that the characteristic appearance 
and reported high detection rates of renal anomalies makes significant under-
diagnosis unlikely. 
 
CONCLUSION 
Our data show that antenatal diagnosis of MCDK is accurate when compared against 
postnatal imaging and can therefore be used to guide antenatal counselling. The 
overall diagnostic accuracy of antenatal diagnosis of MCDK was 91.2%. In about 
19.4% of cases MCDK was associated with renal and extra-renal abnormalities 
highlighting the need for expert evaluation. In 7.2% of cases the initial diagnosis was 
revised, either pre- or postnatally; hydronephrosis was the common differential 
diagnosis. Thus, parents should be counselled that there is a small risk of revision of 
diagnosis, but that – in unilateral disease – this should not alter postnatal outcome. In 
view of our findings it seems reasonable to recommend detailed anatomical 
assessment at initial diagnosis; a repeat ultrasound in later pregnancy; and postnatal 
diagnostic work-up.  
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Figure Legends 
 
Figure 1. Details on the population analysed in the study. 
Figure 2. A and B prenatal features of hydronephrosis; C and D prenatal 
features of MCDK. 
Figure 3. Folow chart of the included studies in the sytematic review. 
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Table 1: Maternal and scan characteristics of patients with and without follow-up; figures are median (IQR); mean (±standard deviation) or n 
(%) as indicated. 
 
 
 
 Patients with follow-up data (n 144 ) Patients lost at follow-up (n 45 ) 
Gravida  2 (±1.55) 2 (±2.04) 
Parity 1 (0-2) 1(1-2) 
BMI 24.6 (±4.6) 25.3 (±5.2) 
Number of prenatal scan 2(2-3) 2 (1-2) 
Mean GA at diagnosis 21.4 (20.5-22.6) 21.8 (20.4-25.8) 
Number of TOP/IUD/NND 38 (26.3%) NA 
Side of MCDK -Left MCDK 55 (38.2%) 
-Right MCDK 47 (32.6%) 
-Bilateral MCDK 25 (17.4%)  
-Left MCDK 18 (40%) 
-Right MCDK 27 (60%) 
-Bilateral MCDK 0 (0%) 
Associated anomalies 28 (19.4%) 1 (2.2%) 
 
BMI: body mass index; TOP: termination of pregnancy; IUD: intrauterine death; NND: neonatal death; MCDK: multicystic dysplastic kidneys 
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Table 2. Individual characteristics, ultrasound findings and post-natal diagnosis of fetuses with non-isolated MCDK 
NOTE TO EDITOR: THIS COULD BE AN ONLINE ONLY TABLE 
 
Case (n) Pregnancy GA at scan 
(weeks) 
MCDK Associated 
prenatal findings 
Outcome GA outcomes Associated 
postnatal 
findings 
 
1 Singleton 21+6 Left MCDK None Livebirth 36+0 17q12 micro 
deletion 
2 Singleton 21+0 Left MCDK None Livebirth 38+4 Right 
hydronephrosis 
3 Singleton 21+6 Right MCDK None Livebirth 39+3 Left duplex 
kidney 
4 Singleton 21+1 Left MCDK None Livebirth 41+3 Left 
hydronephrosis 
5 Singleton 23+6 Right MCDK None Livebirth 39+5 Left 
hydronephrosis 
6 Singleton 23+0 Right MCDK None Livebirth N/A Right ureterocele 
7 Singleton 23+0 Right MCDK None Livebirth 38+4 Left 
hydronephrosis 
8 Singleton 19+3 Right MCDK Suspected 
duodenal 
obstruction/atresia
Livebirth 38+0 Duodenal atresia 
9 Singleton 19+5 Left MCDK Polyhydramnios Livebirth 39+4 Fetal 
macrosomia 
10 Singleton 21+2 Left MCDK SGA IUD 32+0 SGA 
11 Singleton 22+0 Left MCDK Anencephaly NND NA No PM 
assessment 
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12 Singleton 13+2 Bilateral 
MCDK 
Ecephalocele, 
polydactyly 
Termination 13+6 Meckel-Gruber 
syndrome 
13 Singleton 13+0 Bilateral 
MCDK 
Ecephalocele Termination 13+2 Meckel-Gruber 
syndrome 
14 Singleton 19+3 Bilateral 
MCDK 
Ecephalocele, 
anhydramnios 
Termination 20+0 Meckel-Gruber 
syndrome 
15 Singleton 21+3 Bilateral 
MCDK 
Ecephalocele, 
anhydramnios 
Termination 22+0 Meckel-Gruber 
syndrome 
16 Singleton 21+4 Bilateral 
MCDK 
Tetralogy of 
Fallot and lumbar 
scoliosis 
Termination 22+1 Vacterl 
syndrome 
17 Singleton 18+0 Left MCDK Right kidney 
agenesis  
Termination 18+2 Vacterl 
syndrome 
18 Singleton 17+0 Bilateral 
MCDK  
2 vessel cord Termination 17+0 Vacterl 
syndrome 
19 Singleton 21+1 Right MCDK Tetralogy of 
Fallot, bilateral 
talipes 
Termination 23+5 22q11deletion 
20 Singleton 20+4 Left MCDK Major cardiac 
abnormality 
Termination 21+0 Mitral atresia, 
agenesis of the 
right kidney, 
small bilateral 
cervical ribs 
21 Singleton 15+4 Left MCDK Agenesis of the 
right kidney 
Termination NA Left MCDK and 
agenesis of the 
right kidney 
22 Singleton 22+5 Left MCDK Major cardiac Termination 23+0 Double outlet 
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abnormality right ventricle, 
VSD, pulmonary 
stenosis, small 
mitral valve 
23 Singleton 16+4 Bilateral 
MCDK 
Mosaic trisomy 
13 
Termination 17+6 Mosaic trisomy 
13 
24 Singleton 20+2 Left MCDK Kyphoscoliosis 
and lumbar spina 
bifida 
Termination NA No PM 
assessment 
available 
25 Singleton 20+4 Left MCDK Ascites and 
anhydramnios 
Termination 21+0 No PM 
assessment 
available 
26 Singleton 22+4 Right MCDK Agenesis of the 
left kidney 
Termination NA No PM 
assessment 
available 
27 Singleton 21+5 Left MCDK Agenesis of the 
right kidney 
Termination NA No PM 
assessment 
available 
28 Singleton 20+5 Right MCDK Agenesis of the 
left kidney 
Termination 21+3 No PM 
assessment 
available 
 
IUD: intrauterine death; NND: neonatal death; MCDK: multicystic dysplastic kidneys; IUGR: intrauterine fetal growth restriction; PM: post-
mortem 
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Table 3: Individual characteristics, ultrasound findings and post-natal diagnosis of fetuses with a postnatal revision of the MCDK diagnosis 
NOTE TO EDITOR: THIS COULD BE AN ONLINE ONLY TABLE 
 
Case (n) Pregnancy GA at scan 
(weeks) 
MCDK Associated 
prenatal 
findings 
Outcome GA outcomes Postnatal 
findings 
 
1 Singleton 19+0 Right MCDK None Livebirth 41+0 Single cyst 
right kidney 
2 Singleton 20+4 Right MCDK None Livebirth 39+1 Bilateral 
dysplastic 
kidneys 
3 Singleton 21+1 Left MCDK None Livebirth 41+3 Left reflux 
4 Singleton 21+0 Right MCDK  None Livebirth 41+4 Right duplex 
Kidney 
5 Singleton 21+3 Left MCDK None Livebirth 38+1 Adult type 
polycystic 
disease with 
infantile onset 
6 Singleton 24+0 Right MCDK None Livebirth 38+2 Right 
hydronephrosis, 
ureterocoele 
7 Singleton 32+6 Right MCDK None Livebirth 39+2 Right Duplex 
kidney 
 
MCDK: multicystic dysplastic kidneys 
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Table 4. Overall predictive accuracy of ultrasound in detecting MCDK (95% Confidence intervals). 
 
 
 Sensitivity Specificity PPV NPV 
MCDK 98.00%  
(92.96-99.76) 
65.38 %  
(44.33-82.79) 
91.59%  
(84.63-96.08) 
89.47%   
(66.86-98.70) 
 
MCDK: multicystic dysplastic kidneys; PPV: positive predictive value; NPV: negative predictive value 
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Table 5. General characteristics of the 7 studies reporting prenatal detection of MCDK included in the systematic review 
NOTE TO EDITOR: THIS COULD BE AN ONLINE ONLY TABLE 
 
First author Study design MCDK  Mean GA at scan 
(weeks) 
 
Associated prenatal 
findings (n, %) 
Prenatal diagnostic 
accuracy (n, %) 
Outcomes (n, %) 
Winding L et al. 
(2014) 
Multicentre 
retrospective study 
601 21 157 (26.1%) 527/601 (87.7%) 446 (74%): livebirths 
14 (2%): IUD 
141 (23%): TOP 
Moralıoglu S. et al. 
(2013) 
Retrospective study 68 NA 15 (22%) 64/68 (94.1%) 68 (100%): livebirths 
Eckoldt F. et al. 
(2004) 
Retrospective study 107 NA 60 (56%) 56/107 (53.3%) 70 (82.4%): livebirths 
3 (3.5%) IUD 
12 (14.1%): TOP 
Chang LW. et al. 
(2002) 
Retrospective study 28 27 7 (25%) 28/28 (100%) 16 (57.1%): livebirths 
2 (7.1%): IUD 
10 (35.8%): TOP 
Van Eijk L. et al. 
(2002) 
Retrospective study 38 NA 10 (26.3%) 38/38 (100%) 30 (100%). livebirths 
Avni EF. et al. (1987) Retrospective study 13 28 NA 13/13 (100%) 13 (100%) 
Rizzo N. et al. (1987) Retrospective study 16 27 5 (41.7%) 12/12 (75%) 10 (62.4%): livebirths 
3 (18.8%): NND 
3 (18.8%): TOP 
Total  871 25.8 254 738 653 (77.6%): 
livebirths 
19 (2.3%): IUD 
3 (0.4%): NND 
166 (19.7%): TOP 
 
IUD: intrauterine death; NND: neonatal death; MCDK: multicystic dysplastic kidneys; TOP termination of pregnanacy 
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